Related references
Note: Only part of the references are listed.Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations
Franziska Kluwe et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Development and verification of an endogenous PBPK model to inform hydrocortisone replacement dosing in children and adults with cortisol deficiency
Jennifer J. Bonner et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children
Robin Michelet et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
Eva Germovsek et al.
CLINICAL PHARMACOKINETICS (2019)
The circadian rhythm of corticosteroid-binding globulin has little impact on cortisol exposure after hydrocortisone dosing
Johanna Melin et al.
CLINICAL ENDOCRINOLOGY (2019)
Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia
Diala El-Maouche et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
The use of PBPK modeling across the pediatric age range using propofol as a case
Robin Michelet et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2018)
Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults
Johanna Melin et al.
CLINICAL PHARMACOKINETICS (2018)
PBPK in Preterm and Term Neonates: A Review
Robin Michelet et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
Stefan R. Bornstein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Diagnosis and management of adrenal insufficiency
Irina Bancos et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data
Nikolaos Tsamandouras et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations
Peter C. Hindmarsh et al.
CLINICAL ENDOCRINOLOGY (2015)
Diminished 11β-Hydroxysteroid Dehydrogenase Type 2 Activity Is Associated With Decreased Weight and Weight Gain Across the First Year of Life
Samantha L. Rogers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Relationship Between Final Height and Health Outcomes in Adults With Congenital Adrenal Hyperplasia: United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE)
T. S. Han et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Increased Mortality in Patients With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Henrik Falhammar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia
Gabriela P. Finkielstain et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Role of modeling and simulation in pediatric investigation plans
Efthymios Manolis et al.
PEDIATRIC ANESTHESIA (2011)
Management of the child with congenital adrenal hyperplasia
Peter C. Hindmarsh
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Development of CYP2D6 and CYP3A4 in the first year of life
T. N. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Sexual dimorphism in cortisol secretion starts after age 10 in healthy children: urinary cortisol metabolite excretion rates during growth
Stefan A. Wudy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Ontogeny of human hepatic cytochromes P450
Ronald N. Hines
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2007)
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide
Karl Brendel et al.
PHARMACEUTICAL RESEARCH (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
Developmental pharmacology - Drug disposition, action, and therapy in infants and children
GL Kearns et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)